This study firstly sketched the aberrant exon skipping profiling in ccRCC with TCGA dataset, and proved the reliability of this profiling by validating the aberrant splicing of CCDC50 exon 6 in independent ccRCC cohort. The gene discussed is CCDC50; the disease is nonpapillary renal cell carcinoma.